modafinil has been researched along with levodopa in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Drucker-Colín, R; Haro, R; Millán-Aldaco, D; Murillo-Rodríguez, E; Palomero-Rivero, M | 1 |
| Grabowski, J; Herin, DV; Rush, CR | 1 |
| Grabowski, J; Green, CE; Lindsay, JA; Moeller, FG; Rathnayaka, NS; Schmitz, JM; Stotts, AL | 1 |
| Abbar, M; Brunel, L; Fond, G; Lancon, C; Lopez, R; Macgregor, A; Micoulaud-Franchi, JA; Miot, S; Repantis, D; Richieri, R | 1 |
| Bezu, M; Korz, V; Lubec, G; Shanmugasundaram, B | 1 |
| Ando, R; Choudhury, ME; Kannou, M; Kubo, M; Kyaw, WT; Nagai, M; Nishikawa, N; Nomoto, M; Tanaka, J; Yamanishi, Y | 1 |
| Awad, N; Roy, D; Song, J; Zamudio, P | 1 |
2 review(s) available for modafinil and levodopa
| Article | Year |
|---|---|
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Topics: Animals; Behavior Therapy; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Clinical Trials as Topic; Cognition; Dextroamphetamine; Humans; Levodopa; Methylphenidate; Modafinil; Substance-Related Disorders | 2010 |
Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.
Topics: Adult; Attention; Benzhydryl Compounds; Central Nervous System Stimulants; Cognition; Humans; Levodopa; Male; Memory, Episodic; Methylphenidate; Modafinil; Nicotine; Nootropic Agents | 2015 |
1 trial(s) available for modafinil and levodopa
| Article | Year |
|---|---|
A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.
Topics: Adolescent; Adult; Benzhydryl Compounds; Carbidopa; Central Nervous System Stimulants; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Data Interpretation, Statistical; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Modafinil; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Patient Compliance; Secondary Prevention; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for modafinil and levodopa
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzhydryl Compounds; Cannabinoid Receptor Modulators; Dopamine; Drug Interactions; Extracellular Fluid; Levodopa; Male; Modafinil; Neuroprotective Agents; Nucleus Accumbens; Rats; Sleep; Time Factors; Wakefulness | 2007 |
Repeated application of Modafinil and Levodopa reveals a drug-independent precise timing of spatial working memory modulation.
Topics: Animals; Benzhydryl Compounds; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Male; Memory, Short-Term; Modafinil; Rats; Rats, Sprague-Dawley; Spatial Memory | 2016 |
Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Arousal; Benzhydryl Compounds; Biogenic Monoamines; Disease Models, Animal; Disorders of Excessive Somnolence; Drug Therapy, Combination; Levodopa; Male; Mice, Inbred C57BL; Modafinil; Parkinson Disease; Photoperiod | 2018 |
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19.
Topics: Blood Coagulation; Brain Diseases; Carbidopa; Central Nervous System Stimulants; Cognitive Dysfunction; COVID-19; Critical Care; Drug Combinations; Humans; Hypokinesia; Ischemic Stroke; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Modafinil; Rehabilitation; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Ventilator Weaning | 2021 |